Endometrial Receptivity Analysis (ERA) Boosts IVF Success Rates

Endometrial receptivity analysis (ERA), a biotech tool developed by Igenomix, helps optimize embryo transfer timing in IVF, as seen in Tara and Nick’s successful pregnancy after multiple failures. The test analyzes uterine lining genetics to identify the optimal implantation window, increasing IVF success rates for patients with prior embryo transfer failures.

---

Key Takeaways

Endometrial Receptivity Analysis (ERA) for Recurrent IVF Failure Patients

ERA is particularly effective for patients with a history of failed embryo transfers. By identifying the precise uterine lining receptivity window, it increases the likelihood of successful implantation during IVF cycles.

How ERA Analyzes Uterine Lining Genetics to Improve Implantation

The test examines the genetic activity of the endometrium to determine if it is in the receptive phase, which is critical for embryo implantation. This personalized approach reduces trial-and-error in scheduling transfers.

Optimal Embryo Transfer Timing: Why It Matters for IVF Success

Timing embryo transfers during the ‘window of receptivity’ is crucial. ERA ensures transfers occur when the uterine lining is most likely to accept the embryo, improving pregnancy outcomes.

Role of Igenomix’s ERA in Personalized Fertility Treatment Plans

Developed by Igenomix, ERA is integrated into tailored fertility strategies. Dr. Mary Hinckley’s use of the test in Tara and Nick’s case highlights its value in clinical applications.

Tara & Nick’s IVF Success Story Using Endometrial Receptivity Testing

After prior IVF failures, Tara and Nick achieved pregnancy through ERA-guided embryo transfer. Their story demonstrates how advanced biotechnology can address complex infertility challenges.

---

Source: Read full article